CCN2 and Hepatic fibrosis: Quiescent HSCs release EVs containing miR-199a-5p, which can be absorbed by aHSCs and suppress their CCN2 expression level by binding with the 3’-UTR (untranslated region) of CCN2 to reduce liver fibrosis [60].